Biotech Licensing Pro Forma
Healthcare Excel Template (Free Download)
Project risk-adjusted biotech licensing cash flows from development probabilities, milestones, royalties, sales ramps and patent expiry.
professionals from Deloitte
About this pro forma
The full biotech licensing Excel model rolls each indication through preclinical, Phase 1, Phase 2, Phase 3 and approval probabilities. Upfront payments, milestones, tiered royalties, peak sales, market penetration and patent life feed risk-adjusted cash flows.
The pro forma gives biotech investors, pharma licensing teams, corporate development groups and IP specialists a projected view of deal value. Compare indications, deal structures and clinical outcomes for negotiation and go/no-go decisions.
What every model includes
Live formulas, no hardcoded values
Outputs are driven by live formulas, so the workbook updates from its assumptions instead of relying on hardcoded results.
All assumptions in one tab
Inputs are clearly marked in the Assumptions tab and separated from calculations, making it clear what to change and what to leave intact.
Statements always balancing
For integrated-statement models, the balance sheet, cash flow, and supporting schedules tie through properly.
Distinct schedules for clarity
Debt, working capital, taxes, and cash flow can get messy quickly. We group calculations in clear schedules, not across disconnected tabs.
No hidden macros or external links
There are no unexplained external workbook links or macros to undermine auditability or portability.
Changes flow through the model
Update a key driver and see the impact carry through the forecast, financing, and return outputs. We never use hardcoded numbers in formulas.
What's inside the Biotech Licensing Pro Forma
- Phase-by-phase development probability projections
- Upfront, development and commercial milestone outputs
- Royalty rates by indication, volume and escalation
- Peak sales, penetration and launch-timing forecast
- Patent life, exclusivity and generic-erosion projections
- Risk-adjusted NPV, scenarios and deal value
Formatted to IB standards
Named theme colors repaint the whole workbook in one click, on top of an investment-banking structure with clear input, output, and cross-sheet reference styling - brand-ready, institutional-grade, and fully auditable.
Created by ex-finance professionals
Hey, I’m Alex and I created Finamodel.
Over my years in the finance industry I kept building the same models over and over again. Same structure, same assumptions, different logo. So I started building frameworks to turn them into clean, reusable templates.
Every model here is one I’d actually use for a client, and I personally vet each one before it goes up.
I’m not an expert in every industry, but I’ve built enough models to know what belongs in one. And when something is completely foreign to me, I reach out to my network for experts to work on our models with us.
Having a template library on hand cuts a first build from hours to minutes.
Need help finding your model? You’ll find me in the Finamodel app!
Frequently asked
How is value risk-adjusted?+
Cash flows are weighted by the probability of progressing through each phase and achieving approval or commercial milestones.
Can I model multiple indications?+
Yes. Indications carry separate timelines, probabilities, sales assumptions and royalty structures.
What payments are included?+
The pro forma projects upfront consideration, development and sales milestones, and running royalties independently.
How does patent expiry affect value?+
Patent life and post-exclusivity generic discount reduce projected sales and royalties after protection expires.
Have more financial modelling questions? Contact us
Related pro formas
Pharma Pipeline Pro Forma
Clinical trial progression, probability-weighted cash flows, and R&D project valuation for drug candidates.
Medtech Pro Forma
Revenue and profitability model for medical device companies including R&D, regulatory, manufacturing, and distribution.
Gym Pro Forma
Operating model for fitness franchises and independent gyms including membership revenue, class scheduling, and facility utilization.
Hospital Pro Forma
Operating model for hospital systems including inpatient/outpatient volumes, payer mix, DRG reimbursement, and staffing cost drivers.
